Cost analysis of amyotrophic lateral-sclerosis management in China

Asian J Surg. 2023 Feb;46(2):915-916. doi: 10.1016/j.asjsur.2022.07.053. Epub 2022 Aug 5.

Authors

Li-Ping Wang¹, Xin-Yu Zhang², Wen-Bing Chang³, Sheng-Han Zhou³

Affiliations

¹ Department of Neurology, Peking University Third Hospital, Haidian, 100191, China. Electronic address: wanglipingwlp1@126.com.
² Department of Neurology, Peking University Third Hospital, Haidian, 100191, China.
³ School of Reliability and System Engineering, Beihang University, Haidian, 100083, China.

PMID: 35934628
DOI: 10.1016/j.asjsur.2022.07.053

No abstract available

Publication types

Letter

MeSH terms

Amyotrophic Lateral Sclerosis* / therapy
China
Costs and Cost Analysis
Humans
Sclerosis